You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥控股(01099.HK)擬18.6億元收購成大方圓醫藥100%股權
格隆匯 07-24 19:01

格隆匯7月24日丨國藥控股(01099.HK)公佈,於2020年7月24日,公司間接附屬公司國藥控股國大藥房有限公司與遼寧成大股份有限公司簽署產權交易合同,以代價人民幣18.6億元收購遼寧成大持有的成大方圓醫藥集團有限公司100%股權。收購事項通過公開摘牌受讓方式進行。待收購事項完成後,成大方圓將成為國大藥房的全資附屬公司,從而成為公司的間接全資附屬公司。

成大方圓是彙集醫藥零售連鎖和物流配送於一體的區域性大型醫藥流通企業,截至2019年末共擁有門店1,507家遍佈5省19市,覆蓋遼寧、吉林、內蒙古、山東和河北部分重點城市,區域市場集中度優勢明顯。於2020年3月31日,成大方圓未經審計資產總額約為人民幣16.72億元,歸屬於母公司所有者權益約為人民幣6.04億元;截至2019年12月31日止年度,成大方圓經審計營業收入約為人民幣29.37億元。於評估基準日2019年6月30日,以市場法評估的成大方圓股東全部權益價值為人民幣18.6億元。

成大方圓零售業務和所在區域符合國大藥房“成為中國領先、最受信賴的藥店和醫藥保健零售商”的戰略定位,本次收購將有助於國大藥房鞏固在醫藥零售領域全國銷售規模頭部企業地位,進一步提升其市場佔有率及集中度,鞏固優勢區域特別是遼寧區域的領先地位,同時有助於國大藥房在醫藥分開政策背景下提前進行戰略佈局,為承接處方外流等政策紅利做好準備。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account